| Revenue | DKK 189K | -89% |
| EBITDA | DKK -2,6M | -136% |
| Net profit | DKK -90M | -82% |
| Total assets | DKK 247,4M | +37% |
| Equity | DKK -147,4M | -159% |
| Employees | 2 | — |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 256 | 1.679 | 189 |
| Staff expenses | -2.066 | -2.790 | -2.815 |
| EBITDA | -1.809 | -1.111 | -2.626 |
| Depreciation & amort. | -0 | -0 | -0 |
| EBIT | -1.809 | -1.111 | -2.626 |
| Net financials | -6.136 | -48.728 | -87.799 |
| Profit before tax | -7.946 | -49.839 | -90.424 |
| Tax | -0 | -310 | -466 |
| Net profit | -7.946 | -49.529 | -89.958 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 91.450 | 180.846 | 247.367 |
| Equity | -7.906 | -56.945 | -147.383 |
| Long-term debt | 97.850 | 236.568 | 394.404 |
| Short-term debt | 1.505 | 1.224 | 347 |
| Total debt | 99.355 | 237.792 | 394.750 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Creari ApS | Company | 33.3% | 50.0% | 2023 |
OK BIOTECH ApS | Company | 33.3% | 33.3% | 2023 |
Seneca Management Invest ApS | Company | 10.0% | 0.0% | 2023 |
| Person | Role here | Other companies |
|---|---|---|
| Nemanja Stankovic | Management | 0 companies |
| Claus Harald Hommelhoff | Board of Directors | 0 companies |
| Ole Kaae Hansen | Chairman | 0 companies |
| Rasmus Kramer Søes Dohn | Board of Directors | 0 companies |